Panel A. MRSA prevalence, defined as the proportion of MRSA among all
tested samples, reported in selected countries between year 2000 and 2016. For
studies that report prevalence for more than one year, the midpoint of the study
is reported as the study year. Bubble sizes reflect the study sample size for
each observation. Panel B. MRSA resistance proportion, defined as as the
proportion of MRSA among all S. aureus isolates, reported in selected countries
between year 2000 and 2016. For studies that report prevalence for more than one
year, the midpoint of the study is reported as the study year. Bubble sizes
reflect the study sample size for each observation. Panel C. Number of
publications that report MRSA prevalence in selected countries in year 2000
– 2017. Panel D. Number of publications that report MRSA prevalence in
selected countries in year 2000 – 2017.